EUVIMEDEUVIMED entdecken
Crossref

AKR1B1-dependent ferroptosis defense contributes to KRASG12C inhibitor resistance in pancreatic ductal adenocarcinoma

Xiaoqing Guan, Wenyan Yang, Zhiyang Yao, Fei Cao, Jiaxuan Liu, Kai Miao, Xuanming Mao, Guogui Sun, Lele Zhang, Jiang-Jiang Qin

Drug Resistance Updates · 2027-01 · 90 · 101508

DOI: 10.1016/j.drup.2026.101508 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2027-01. Verfasst von Xiaoqing Guan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepato-Pancreato-Biliary & Gastric Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, China. Electronic address: gu…. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Medical Science and Technology Project of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AKR1B1Acquired resistanceEpalrestatFerroptosisKRAS(G12C)Pancreatic ductal adenocarcinoma

Autor:innen und Institutionen

  • Department of Hepato-Pancreato-Biliary & Gastric Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, China. Electronic address: guanxq@zjcc.org.cn.
  • Center for Innovative Drug Research, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310018, China; College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou,…
  • MOE Frontier Science Centre for Precision Oncology, University of Macau, 999078, Macao Special Administrative Region of China.
  • Key Laboratory of Precision Medicine for Medical-Industrial Integration, Department of Oncology, North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei 063000, China.
  • Key Laboratory of Precision Medicine for Medical-Industrial Integration, Department of Oncology, North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei 063000, China. Electronic address: g…
  • School of Preclinical Medicine, Chengdu University, Chengdu 610106, China. Electronic address: zhanglele@cdu.edu.cn.

Förderung

  • Medical Science and Technology Project of Zhejiang Province

Zitieren

APA

Guan, X., Yang, W., Yao, Z., Cao, F., Liu, J., Miao, K., Mao, X., Sun, G., Zhang, L., & Qin, J. J. (2027). AKR1B1-dependent ferroptosis defense contributes to KRASG12C inhibitor resistance in pancreatic ductal adenocarcinoma. Drug Resistance Updates, 90, 101508. https://doi.org/10.1016/j.drup.2026.101508

Vancouver

Guan X, Yang W, Yao Z, Cao F, Liu J, Miao K, et al. AKR1B1-dependent ferroptosis defense contributes to KRASG12C inhibitor resistance in pancreatic ductal adenocarcinoma. Drug Resistance Updates. 2027;90:101508. doi:10.1016/j.drup.2026.101508

BibTeX
@article{Guan2027,
  author = {Guan, Xiaoqing and Yang, Wenyan and Yao, Zhiyang and Cao, Fei and Liu, Jiaxuan and Miao, Kai and Mao, Xuanming and Sun, Guogui and Zhang, Lele and Qin, Jiang-Jiang},
  title = {AKR1B1-dependent ferroptosis defense contributes to KRASG12C inhibitor resistance in pancreatic ductal adenocarcinoma},
  journal = {Drug Resistance Updates},
  year = {2027},
  volume = {90},
  pages = {101508},
  doi = {10.1016/j.drup.2026.101508}
}
Kostenlos starten →